Table 2.
Comparison of clinical characteristics of the study sample (n = 120, n, %).
| Variable | Control (n = 30) | CLC (n = 30) | APA (n = 30) | APA + CLC (n = 30) | χ2 | P | |
|---|---|---|---|---|---|---|---|
| Primary disease | Hypertension | 11 (36.67) | 8 (26.67) | 10 (33.33) | 9 (30.00) | 1.498 | 0.997 |
| Diabetes | 10 (33.33) | 12 (40.00) | 10 (33.33) | 10 (33.33) | |||
| Nephropathy | 8 (26.67) | 9 (30.00) | 9 (30.00) | 9 (30.00) | |||
| Other | 1 (3.33) | 1 (3.33) | 1 (3.33) | 2 (6.67) | |||
|
| |||||||
| Complications | 0 | 3 (10.00) | 4 (13.33) | 3 (10.00) | 5 (16.67) | 1.982 | 0.992 |
| 1 | 14 (46.67) | 15 (50.00) | 16 (53.33) | 12 (40.00) | |||
| 2 | 7 (23.33) | 7 (23.33) | 6 (20.00) | 7 (23.33) | |||
| ≥3 | 6 (20.00) | 4 (13.33) | 5 (16.67) | 6 (20.00) | |||
|
| |||||||
| Dialysis duration (years) | ＜1 | 7 (23.33) | 7 (23.33) | 6 (20.00) | 8 (26.67) | 0.764 | 0.993 |
| 1∼2 | 11 (36.67) | 13 (43.33) | 12 (40.00) | 11 (36.67) | |||
| ≥3 | 12 (40.00) | 10 (33.33) | 12 (40.00) | 11 (36.67) | |||
|
| |||||||
| AVF use experiences (month) | ＜6 | 6 (20.00) | 8 (26.67) | 7 (23.33) | 8 (26.67) | 1.836 | 0.994 |
| 6∼ | 7 (23.33) | 8(26.67) | 8 (26.67) | 9 (30.00) | |||
| 12∼ | 10 (33.34) | 10 (33.34) | 9 (30.00) | 8 (26.67) | |||
| ≥36 | 7 (23.33) | 4 (13.33) | 6 (20.00) | 5 (16.67) | |||
CLC = compound lidocaine cream; APA = auricular point acupressure; PHC = physiological comfort; PSC = psychological comfort; SC = social comfort; EC = environmental comfort.